Viewing Study NCT06922604


Ignite Creation Date: 2025-12-24 @ 7:58 PM
Ignite Modification Date: 2025-12-30 @ 10:18 PM
Study NCT ID: NCT06922604
Status: RECRUITING
Last Update Posted: 2025-11-07
First Post: 2025-04-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Glofitamab With Obinutuzumab Pre-treatment for the Treatment of Central Nervous System Lymphoma
Sponsor: City of Hope Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module